SNY Sep 2024 50.000 put
- Yahoo Finance UK
Trending tickers: TSMC, Novavax, Anglo American and IAG
The latest investor updates on stocks that are trending on Friday
- Bloomberg
Sanofi Inks $1.2 Billion Vaccine Licensing Deal With Novavax
(Bloomberg) -- Sanofi and Novavax Inc. signed a licensing agreement that includes commercializing a combined Covid-19 and flu shot. Most Read from BloombergBiden Set to Impose Tariffs on China EVs, Strategic SectorsApple Apologizes for iPad Pro Ad, Scraps Plan to Air It on TV‘Seriously Underwater’ Home Mortgages Tick Up Across the USMarjorie Taylor Greene Finally Got What She Deserved: DefeatNovavax will receive $500 million in upfront payments as well as $700 million in development, regulatory
- Reuters
UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning
Novavax on Friday removed doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi for COVID-19 vaccines in exchange for a stake that doubles the U.S. biotech's market value. Sanofi will take a 4.9% stake in the U.S. drugmaker for $70 million. The deal, which entitles Novavax to an upfront cash payment of $500 million, milestone-based payments and proceeds from the equity stake sale, lifted shares of the Gaithersburg, Maryland-based company 55.5% to $6.95 before the opening bell.
